CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Ustekinumab

Last Updated: January 7, 2009
Result type: Reports
Project Number: S0156
Product Line: Common Drug Review

Generic Name: Ustekinumab

Brand Name: Stelara

Manufacturer: Janssen-Ortho Inc.

Indications: Psoriasis

Submission Type: New

Project Status: Complete

Date Recommendation Issued: June 17, 2009

Recommendation Type: List with clinical criteria and/or conditions